Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.
NCT ID: NCT05719181
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
32 participants
INTERVENTIONAL
2021-12-06
2023-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BMP Effect on Implant Stability and Marginal Bone Level After Immediate Placement
NCT07240493
Modified Periosteal Inhibition with Simultaneous Implant Placement in Aesthetic Zone
NCT06519773
THE EFFICACY OF RESORBABLE PLATES VERSUS TITANIUM PLATES IN TERMS OF STABILITY IN MANDIBULAR FRACTURES.
NCT05547763
Immediate Implant in Posterior Mandible Region
NCT07027904
Expression of Epithelial-Mesenchymal Transition Associated Markers in Peri-implant Tissues
NCT05832541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary outcome association of the effect of other factors (ridge dimension, bone density) on dental implant stability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
group consist of 16 patients with no protein application
rhBMP-2
Recombinant Human Bone Morphogenetic Protein-2 with an Absorbable Collagen Sponge .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rhBMP-2
Recombinant Human Bone Morphogenetic Protein-2 with an Absorbable Collagen Sponge .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systemic healthy individuals ,Age more than18 years.
* Healed edentulous area for at least 6 months after tooth extraction (delayed implant protocol).
* Patients have at least two missing teeth in the jaw (canine to 1st molar area) indicated for the dental implant.
Exclusion Criteria
* Previous implantation or augmentation of the same region.
* The need for additional bone augmentation procedures (such as maxillary sinus augmentation)
* Partial or total edentulous ridge associated with a severe knife-edge ridge .
* Acute infection or any pathological lesion a the implant site.
* Allergy to one of the materials to be used during operation.
* Pregnancy.
* Radiation therapy, bisphosphonate drugs , Osteoradionecrosis.
25 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Baghdad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdullah Ali Abbas
master student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adbullah Al Abbas, B.D.S
Role: PRINCIPAL_INVESTIGATOR
University of Baghdad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Baghdad
Baghdad, Alresafa, Iraq
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
B.D.S
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
528622
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.